← Open Payments lookup

MANUEL PASCHINGER: Open Payments

NPI 1679286611 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,521 in 115 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $332 · 2025 $2,521

Food & beverage: $2,521
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.30$844
Teva Pharmaceuticals USA, Inc.19$332
Vanda Pharmaceuticals Inc.14$274
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$266
Otsuka America Pharmaceutical, Inc.11$243
Lundbeck LLC7$133
Janssen Pharmaceuticals, Inc6$131
Alkermes, Inc.5$102
Supernus Pharmaceuticals, Inc.4$98
ABBVIE INC.2$49

Products named: INGREZZA, REXULTI, CAPLYTA, UZEDY, AUSTEDO XR, HETLIOZ, INVEGA SUSTENNA, FANAPT.

Industry payments across CA — which companies pay providers there.